Share price of DexCom, Inc. DXCM jumped 4.8% on Aug 25, following the FDA approval of the DexCom G5 Mobile Continuous Glucose Monitoring (CGM) System. The fully portable product is the first and ...
A new diabetes device may make tracking blood sugars and taking medication easier. The U.S. Food and Drug Administration said Tuesday that the Dexcom G5 continuous glucose monitoring system (CGM) can ...
The t:slim X2 Pump can operate as a stand-alone insulin pump without CGM, or be paired with the Dexcom G5 Mobile CGM to track glucose continuously and display that information directly on the pump’s ...
First and only mobile-connected CGM with no confirmatory finger sticks needed for treatment decisions* for adults and children as young as 2 years of age. The new system is the first mobile-connected ...
BEDFORD, MA--(Marketwired - Aug 5, 2014) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, and DexCom, Inc (NASDAQ: DXCM ...
The US Food and Drug Administration (FDA) has approved the first continuous glucose monitoring (CGM) system that sends data directly to a smartphone and does not require a separate receiver, according ...
The Centers for Medicare & Medicaid Services published criteria for coverage of therapeutic continuous glucose monitoring systems. Type 1 and Type 2 diabetes patients covered by Medicare who are on ...
For the first time, the US Food and Drug Administration has approved the use of a continuous glucose monitoring (CGM) system to replace finger-stick testing for determining insulin doses. The decision ...
"The Dexcom G5 Mobile CGM System lets users see and treat their diabetes in a whole new way - right on a smart device^ and without the need to perform confirmatory finger sticks for treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results